A clinical trial to study the comparison two treatment method of ultrasound guided autologous blood injection and extracorporeal shockwave treatment in chronic disease of behind the ankle(achilles tendon).

Efficacy of ultrasound guided autologous blood injection versus extracorporeal shock wave therapy in chronic achilles tendinopathy.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/10/021669

Enrollment

Registered

2019-10-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: Autologous blood injection: Participants will be given ultrasound guided single injection at the site of maximal tenderness. All participants will be injected 3mL of their own blood tak

Eligibility

Inclusion criteria

Inclusion criteria: 1.Clinical feature of tendinopathy >6months 2.Ultrasound features of tendinopathy 3.Normal hemoglobin value 4.Refractory to traditional conservative treatment 5.Willingness to comply with treatment and follow ups

Exclusion criteria

Exclusion criteria: 1. Platelet value 2. Bleeding disorders 3. History of steroid injection or foot surgery in last 3 months 4. History of any malignancy 5. Systemic illness including ischemic heart disease, diabetes, rheumatoid arthritis, hepatitis 6. Any fracture, bony malformation, articular lesions at foot 7. Haglunds deformity 8. Patients with congenital or acquired deformity of knee and ankle 9. Patients on anticoagulants therapy 10. NSAIDs intake 1 week prior to treatment 11. Pregnancy

Design outcomes

Primary

Measure	Time frame
1. Visual Analog Scale(VAS) 2. Victoria Institute of Sport Assessment- Achilles questionnairre(VISA-A) Timepoint: baseline, 4weeks, 12 weeks, 24weeks	—

Secondary

Measure	Time frame
Ultrasonographic findingTimepoint: baseline, 4 weeks, 12 weeks, 24 weeks	—

Countries

India

Contacts

Public ContactN ROMI SINGH

Regional Institute of Medical Science

dr.romi.singh@gmail.com9436025822

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026